XSpray Pharma shares rise 10% on the day
- Insider
- Blake Leitch
- Role
- Closely associated: Managing director (CEO)
- Company
- XSpray Pharma (XSPRAY)
- Transaction
- Buy
- Shares
- 50,000
- Amount
- SEK 475K
- Trade date
- Sep 28, 2026
- Filed
- Sep 29, 2026, 1 day after the trade
- Source
- Finansinspektionen ↗
XSpray Pharma shares rose 10.3% to SEK 11.80, up from SEK 10.70 at the previous close. Two insiders disclosed purchases since Aug 20.
Blake Leitch, closely associated with the managing director (Verkställande direktör), disclosed a purchase of 50,000 shares at SEK 9.51 on September 28, 2026. Against the first close after the purchase, SEK 9.95 on Sep 29, 2026, the share is up 18.6%.
Anders Bladh, closely associated with a board member (Styrelseledamot), disclosed a purchase of 3,690 shares at SEK 10.50 on August 20, 2026. The price quoted is from 13:00 CET and is delayed by 15 to 20 minutes.
XSPRAY +10.3% on the day, close Oct 30
Today+10.3%At 13:00 CET, delayed
PriceSEK 11.80Previous close SEK 10.70
Disclosed buys2In the last 90 days
Since purchase+18.6%Blake Leitch, Sep 28